BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vancells Lujan P, Viñas Esmel E, Sacanella Meseguer E. Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. Nutrients 2021;13:1442. [PMID: 33923255 DOI: 10.3390/nu13051442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 BinMowyna MN, AlFaris NA, Al-Sanea EA, AlTamimi JZ, Aldayel TS. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis. Arch Physiol Biochem 2022;:1-16. [PMID: 35254877 DOI: 10.1080/13813455.2022.2046106] [Reference Citation Analysis]
2 Finer N. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. Diabetes Obes Metab 2021. [PMID: 34622555 DOI: 10.1111/dom.14569] [Reference Citation Analysis]
3 Almohawes ZN, El-kott A, Morsy K, Shati AA, El-kenawy AE, Khalifa HS, Elsaid FG, Abd-lateif AM, Abu-zaiton A, Ebealy ER, Abdel-daim MM, Ghanem RA, Abd-ella EM. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats. Archives of Physiology and Biochemistry. [DOI: 10.1080/13813455.2021.2024578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zheng X, Zhang X, Liu Y, Zhu L, Liang X, Jiang H, Shi G, Zhao Y, Zhao Z, Teng Y, Pan K, Zhang J, Yin Z. Arjunolic acid from Cyclocarya paliurus ameliorates nonalcoholic fatty liver disease in mice via activating Sirt1/AMPK, triggering autophagy and improving gut barrier function. Journal of Functional Foods 2021;86:104686. [DOI: 10.1016/j.jff.2021.104686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yamamoto M, Yoshioka Y, Kitakaze T, Yamashita Y, Ashida H. Preventive effects of black soybean polyphenols on non-alcoholic fatty liver disease in three different mouse models. Food Funct 2022. [PMID: 35015019 DOI: 10.1039/d1fo03541j] [Reference Citation Analysis]
6 Policarpo S, Machado M, Barreira D, Cortez-pinto H. NAFLD Nutritional Management: Results from a Multidisciplinary Approach. GE Port J Gastroenterol. [DOI: 10.1159/000519932] [Reference Citation Analysis]
7 Gindlhuber J, Schinagl M, Liesinger L, Darnhofer B, Tomin T, Schittmayer M, Birner-gruenberger R. Hepatocyte Proteome Alterations Induced by Individual and Combinations of Common Free Fatty Acids. IJMS 2022;23:3356. [DOI: 10.3390/ijms23063356] [Reference Citation Analysis]
8 Ziolkowska S, Binienda A, Jabłkowski M, Szemraj J, Czarny P. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:11128. [PMID: 34681787 DOI: 10.3390/ijms222011128] [Reference Citation Analysis]
9 Zaiou M, Amrani R, Rihn B, Hajri T. Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. Biomedicines 2021;9:1256. [PMID: 34572442 DOI: 10.3390/biomedicines9091256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ezhilarasan D, Lakshmi T, Kosuru R. A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/9233650] [Reference Citation Analysis]